1 2 “Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development”.Current Medicinal Chemistry16(27): 3480–675.(2009).doi:10.2174/092986709789057635.PMID19515014.
↑ Müller CE(November 2009).“Prodrug approaches for enhancing the bioavailability of drugs with low solubility”.Chemistry & Biodiversity6(11): 2071–83.doi:10.1002/cbdv.200900114.PMID19937841.